Annual Total Long Term Liabilities
$20.55 B
-$1.50 B-6.80%
31 December 2023
Summary:
Abbott Laboratories annual total long term liabilities is currently $20.55 billion, with the most recent change of -$1.50 billion (-6.80%) on 31 December 2023. During the last 3 years, it has fallen by -$7.09 billion (-25.66%). ABT annual total long term liabilities is now -43.31% below its all-time high of $36.24 billion, reached on 31 December 2017.ABT Long Term Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Long Term Liabilities
$19.43 B
-$271.00 M-1.38%
30 September 2024
Summary:
Abbott Laboratories quarterly total long term liabilities is currently $19.43 billion, with the most recent change of -$271.00 million (-1.38%) on 30 September 2024. Over the past year, it has dropped by -$1.93 billion (-9.03%). ABT quarterly long term liabilities is now -46.40% below its all-time high of $36.24 billion, reached on 31 December 2017.ABT Quarterly Long Term Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
ABT Long Term Liabilities Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -6.8% | -9.0% |
| 3 y3 years | -25.7% | -26.1% |
| 5 y5 years | -25.1% | -25.4% |
ABT Long Term Liabilities High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3 years | -25.7% | at low | -26.1% | +0.1% |
| 5 y | 5 years | -25.7% | at low | -29.7% | +0.1% |
| alltime | all time | -43.3% | +2720.3% | -46.4% | +2698.3% |
Abbott Laboratories Long Term Liabilities History
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2024 | - | $19.43 B(-1.4%) |
| June 2024 | - | $19.70 B(+1.5%) |
| Mar 2024 | - | $19.40 B(-5.6%) |
| Dec 2023 | $20.55 B(-6.8%) | $20.55 B(-3.8%) |
| Sept 2023 | - | $21.35 B(-1.1%) |
| June 2023 | - | $21.60 B(-2.0%) |
| Mar 2023 | - | $22.03 B(-0.1%) |
| Dec 2022 | $22.04 B(-15.4%) | $22.04 B(-6.4%) |
| Sept 2022 | - | $23.55 B(-6.1%) |
| June 2022 | - | $25.09 B(-2.5%) |
| Mar 2022 | - | $25.73 B(-1.3%) |
| Dec 2021 | $26.07 B(-5.7%) | $26.07 B(-0.8%) |
| Sept 2021 | - | $26.29 B(-1.3%) |
| June 2021 | - | $26.63 B(+0.3%) |
| Mar 2021 | - | $26.54 B(-4.0%) |
| Dec 2020 | $27.64 B(+7.4%) | $27.64 B(+1.6%) |
| Sept 2020 | - | $27.19 B(+0.6%) |
| June 2020 | - | $27.02 B(+5.8%) |
| Mar 2020 | - | $25.54 B(-0.7%) |
| Dec 2019 | $25.72 B(-6.3%) | $25.72 B(-1.2%) |
| Sept 2019 | - | $26.03 B(-5.2%) |
| June 2019 | - | $27.47 B(+0.4%) |
| Mar 2019 | - | $27.37 B(-0.3%) |
| Dec 2018 | $27.44 B(-24.3%) | $27.44 B(-1.9%) |
| Sept 2018 | - | $27.96 B(-2.5%) |
| June 2018 | - | $28.69 B(-5.3%) |
| Mar 2018 | - | $30.30 B(-16.4%) |
| Dec 2017 | $36.24 B(+43.3%) | $36.24 B(+12.9%) |
| Sept 2017 | - | $32.09 B(-1.4%) |
| June 2017 | - | $32.56 B(-0.4%) |
| Mar 2017 | - | $32.69 B(+29.3%) |
| Dec 2016 | $25.29 B(+135.6%) | $25.29 B(+146.0%) |
| Sept 2016 | - | $10.28 B(-0.8%) |
| June 2016 | - | $10.36 B(-0.4%) |
| Mar 2016 | - | $10.40 B(-3.1%) |
| Dec 2015 | $10.73 B(+18.0%) | $10.73 B(-8.6%) |
| Sept 2015 | - | $11.75 B(-0.5%) |
| June 2015 | - | $11.81 B(-0.7%) |
| Mar 2015 | - | $11.90 B(+30.8%) |
| Dec 2014 | $9.10 B(+11.3%) | $9.10 B(+4.6%) |
| Sept 2014 | - | $8.70 B(+9.9%) |
| June 2014 | - | $7.92 B(-0.9%) |
| Mar 2014 | - | $7.99 B(-2.3%) |
| Dec 2013 | $8.18 B(-69.9%) | $8.18 B(-9.3%) |
| Sept 2013 | - | $9.01 B(-5.7%) |
| June 2013 | - | $9.56 B(-0.4%) |
| Mar 2013 | - | $9.60 B(-64.6%) |
| Dec 2012 | $27.14 B(+33.9%) | $27.14 B(+36.6%) |
| Sept 2012 | - | $19.87 B(-1.5%) |
| June 2012 | - | $20.17 B(+0.4%) |
| Mar 2012 | - | $20.09 B(-0.9%) |
| Dec 2011 | $20.27 B(-1.3%) | $20.27 B(+3.8%) |
| Sept 2011 | - | $19.53 B(-0.9%) |
| June 2011 | - | $19.69 B(-0.1%) |
| Mar 2011 | - | $19.71 B(-4.1%) |
| Dec 2010 | $20.55 B(+24.8%) | $20.55 B(+1.2%) |
| Sept 2010 | - | $20.31 B(+8.6%) |
| June 2010 | - | $18.70 B(+8.9%) |
| Mar 2010 | - | $17.16 B(+4.2%) |
| Dec 2009 | $16.47 B(+23.7%) | $16.47 B(+3.3%) |
| Sept 2009 | - | $15.95 B(+1.8%) |
| June 2009 | - | $15.67 B(-0.1%) |
| Mar 2009 | - | $15.68 B(+17.8%) |
| Dec 2008 | $13.31 B(+3.7%) | $13.31 B(+3.6%) |
| Sept 2008 | - | $12.85 B(-1.9%) |
| June 2008 | - | $13.10 B(+5.4%) |
| Mar 2008 | - | $12.43 B(-3.2%) |
| Dec 2007 | $12.83 B(+26.1%) | $12.83 B(+31.9%) |
| Sept 2007 | - | $9.73 B(-0.8%) |
| June 2007 | - | $9.81 B(+1.5%) |
| Mar 2007 | - | $9.66 B(-5.0%) |
| Dec 2006 | $10.17 B | $10.17 B(-0.6%) |
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2006 | - | $10.23 B(-8.5%) |
| June 2006 | - | $11.18 B(+61.4%) |
| Mar 2006 | - | $6.93 B(-5.2%) |
| Dec 2005 | $7.31 B(-4.0%) | $7.31 B(+25.8%) |
| Sept 2005 | - | $5.81 B(-21.0%) |
| June 2005 | - | $7.35 B(+0.6%) |
| Mar 2005 | - | $7.31 B(-4.0%) |
| Dec 2004 | $7.62 B(+26.9%) | $7.62 B(+4.1%) |
| Sept 2004 | - | $7.31 B(+1.1%) |
| June 2004 | - | $7.24 B(-4.6%) |
| Mar 2004 | - | $7.59 B(+26.4%) |
| Dec 2003 | $6.00 B(-8.9%) | $6.00 B(-4.0%) |
| Sept 2003 | - | $6.25 B(-6.2%) |
| June 2003 | - | $6.66 B(+1.5%) |
| Mar 2003 | - | $6.57 B(-0.4%) |
| Dec 2002 | $6.59 B(+4.5%) | $6.59 B(+3.1%) |
| Sept 2002 | - | $6.40 B(+1.6%) |
| June 2002 | - | $6.30 B(-1.1%) |
| Mar 2002 | - | $6.37 B(+0.9%) |
| Dec 2001 | $6.31 B(+161.3%) | $6.31 B(+0.7%) |
| Sept 2001 | - | $6.27 B(+1.8%) |
| June 2001 | - | $6.16 B(+105.9%) |
| Mar 2001 | - | $2.99 B(+23.8%) |
| Dec 2000 | $2.41 B(-4.4%) | $2.41 B(+1.4%) |
| Sept 2000 | - | $2.38 B(-8.1%) |
| June 2000 | - | $2.59 B(+0.2%) |
| Mar 2000 | - | $2.59 B(+2.4%) |
| Dec 1999 | $2.53 B(-0.5%) | $2.53 B(-1.9%) |
| Sept 1999 | - | $2.58 B(+1.6%) |
| June 1999 | - | $2.54 B(-0.4%) |
| Mar 1999 | - | $2.55 B(+0.2%) |
| Dec 1998 | $2.54 B(+25.3%) | $2.54 B(-0.9%) |
| Sept 1998 | - | $2.56 B(+8.0%) |
| June 1998 | - | $2.37 B(+5.7%) |
| Mar 1998 | - | $2.25 B(+10.8%) |
| Dec 1997 | $2.03 B(+3.4%) | $2.03 B(+0.8%) |
| Sept 1997 | - | $2.01 B(+1.5%) |
| June 1997 | - | $1.98 B(+0.8%) |
| Mar 1997 | - | $1.97 B(+0.3%) |
| Dec 1996 | $1.96 B(+60.1%) | $1.96 B(+17.6%) |
| Sept 1996 | - | $1.67 B(+20.3%) |
| June 1996 | - | $1.39 B(+10.5%) |
| Mar 1996 | - | $1.25 B(+2.4%) |
| Dec 1995 | $1.23 B(+22.7%) | $1.23 B(-0.1%) |
| Sept 1995 | - | $1.23 B(+1.2%) |
| June 1995 | - | $1.21 B(+17.6%) |
| Mar 1995 | - | $1.03 B(+3.2%) |
| Dec 1994 | $998.46 M(+8.7%) | $998.46 M(+0.9%) |
| Sept 1994 | - | $989.90 M(+3.4%) |
| June 1994 | - | $957.76 M(+1.7%) |
| Mar 1994 | - | $941.53 M(+2.5%) |
| Dec 1993 | $918.71 M(+13.3%) | $918.71 M(+11.8%) |
| Sept 1993 | - | $822.10 M(+10.1%) |
| June 1993 | - | $746.80 M(+7.6%) |
| Mar 1993 | - | $694.20 M(-14.4%) |
| Dec 1992 | $811.10 M(-1.4%) | $811.10 M(-5.0%) |
| Sept 1992 | - | $853.60 M(+1.5%) |
| June 1992 | - | $841.00 M(-1.3%) |
| Mar 1992 | - | $852.50 M(+3.6%) |
| Dec 1991 | $823.00 M(+13.0%) | $823.00 M(+3.7%) |
| Sept 1991 | - | $793.50 M(+0.2%) |
| June 1991 | - | $792.20 M(-0.3%) |
| Mar 1991 | - | $794.40 M(+9.0%) |
| Dec 1990 | $728.50 M(-1.8%) | $728.50 M(-9.0%) |
| Sept 1990 | - | $800.90 M(+3.2%) |
| June 1990 | - | $775.70 M(+0.6%) |
| Mar 1990 | - | $771.10 M(+4.0%) |
| Dec 1989 | $741.60 M(-19.5%) | $741.60 M(-19.5%) |
| Dec 1988 | $920.80 M(+14.3%) | $920.80 M(+14.3%) |
| Dec 1987 | $805.40 M(+2.8%) | $805.40 M(+2.8%) |
| Dec 1986 | $783.20 M(-3.2%) | $783.20 M(-3.2%) |
| Dec 1985 | $809.20 M(+5.9%) | $809.20 M(+5.9%) |
| Dec 1984 | $763.80 M | $763.80 M |
FAQ
- What is Abbott Laboratories annual total long term liabilities?
- What is the all time high annual total long term liabilities for Abbott Laboratories?
- What is Abbott Laboratories annual total long term liabilities year-on-year change?
- What is Abbott Laboratories quarterly total long term liabilities?
- What is the all time high quarterly long term liabilities for Abbott Laboratories?
- What is Abbott Laboratories quarterly long term liabilities year-on-year change?
What is Abbott Laboratories annual total long term liabilities?
The current annual total long term liabilities of ABT is $20.55 B
What is the all time high annual total long term liabilities for Abbott Laboratories?
Abbott Laboratories all-time high annual total long term liabilities is $36.24 B
What is Abbott Laboratories annual total long term liabilities year-on-year change?
Over the past year, ABT annual total long term liabilities has changed by -$1.50 B (-6.80%)
What is Abbott Laboratories quarterly total long term liabilities?
The current quarterly long term liabilities of ABT is $19.43 B
What is the all time high quarterly long term liabilities for Abbott Laboratories?
Abbott Laboratories all-time high quarterly total long term liabilities is $36.24 B
What is Abbott Laboratories quarterly long term liabilities year-on-year change?
Over the past year, ABT quarterly total long term liabilities has changed by -$1.93 B (-9.03%)